Search Results - deb+chatterjee

3 Results Sort By:
Method for Targeted Therapeutic Delivery of Proteins into Cells
Abstract: Current methods to deliver proteins into cells (e.g., using retrovirus, DNA transfection, protein transduction, microinjection, complexing the protein with lipids, etc.) have many shortcomings, such as lack of target specificity toxicity, or unwanted random integration into the host chromosome.  Protein transduction is an emerging technology...
Published: 4/8/2024   |   Inventor(s): Deb Chatterjee, Stanislaw Kaczmarczyk
Keywords(s): virus-like particles, VLP
Category(s): TherapeuticArea > Oncology, Collaboration Sought > Licensing, Application > Non-Medical Devices, Application > Medical Devices
Virus-Like Particles That Can Deliver Proteins and RNA
Abstract: The National Cancer Institute's Protein Expression Laboratory seeks parties interested in licensing the novel delivery of RNA to mammalian cells using virus-like particles. Current methods of delivering proteins or RNA to mammalian cells are limited by a lack of target specificity and toxicity, among other shortcomings.  NCI researchers have...
Published: 4/8/2024   |   Inventor(s): Stanislaw Kaczmarczyk, Deb Chatterjee
Keywords(s): antibody synthesis, Protein Expression, RNA delivery, virus-like particles
Category(s): Application > Therapeutics, TherapeuticArea > Oncology, Collaboration Sought > Licensing, TherapeuticArea > Infectious Disease
Cancer Immunotherapy Using Virus-like Particles
Abstract: One major challenge in the development of effective cancer therapies is a lack of universal, cancer specific markers in target cells. The current standard therapies rely on surgery, chemotherapy, and radiation therapy. Such procedures lead to a population of resistant cancer cells that makes further applications of chemotherapy/radiation therapy...
Published: 4/8/2024   |   Inventor(s): Stanislaw Kaczmarczyk, Deb Chatterjee
Keywords(s): virus-like particle, VLP
Category(s): TherapeuticArea > Oncology, Application > Therapeutics, Collaboration Sought > Licensing
© 2024. All Rights Reserved. Powered by Inteum